Despite high regional demand for vaccines worth well over US$ 1 billion annually, Africa’s vaccine industry is still nascent, fulfilling approximately 0.1% of global supply. In response, the African Union has set the ambitious goal, to develop, produce, and supply more than 60% of the vaccine doses required on the continent by 2040. Gavi, the Vaccine Alliance and other international partners work to actively support this agenda.

As part of Gavi’s four pillar strategy, Gavi is working on a proposal for a new financial instrument, an AMC, that could level the playing field as new manufacturers enter a nascent sector on the continent, to build vaccine supply resilience and support overall market health.

More information on the strategy can be found in this report: Expanding sustainable vaccine manufacturing in Africa:  Priorities for Support.

We are keen to benefit from a wide range of perspectives, including civil society and community representatives as we scope this potential instrument. To this end, we would like to invite you to a virtual session on the AMC concept and early design considerations.

Date and time:  June 9, 4:00 – 5:00 pm (CET).

This session will be dedicated to discussing your questions and feedback.  

Please confirm your organization’s interest and participation by registering here, before May 31^st.

Kindly reach out to dkongere@gavi.org in case of any questions.